BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34278507)

  • 41. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
    Liu Y; Gao S; Du Q; Zhao Q
    Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
    Luan W; Li L; Shi Y; Bu X; Xia Y; Wang J; Djangmah HS; Liu X; You Y; Xu B
    Oncotarget; 2016 Sep; 7(39):63901-63912. PubMed ID: 27564100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MALAT1 induces osteosarcoma progression by targeting miR-206/CDK9 axis.
    Ren D; Zheng H; Fei S; Zhao JL
    J Cell Physiol; 2018 Jan; 234(1):950-957. PubMed ID: 30076726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42.
    Chou J; Wang B; Zheng T; Li X; Zheng L; Hu J; Zhang Y; Xing Y; Xi T
    Biochem Biophys Res Commun; 2016 Mar; 472(1):262-9. PubMed ID: 26926567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension.
    Wang D; Xu H; Wu B; Jiang S; Pan H; Wang R; Chen J
    Int J Mol Med; 2019 Sep; 44(3):871-884. PubMed ID: 31257528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
    Peng Y; Fang X; Yao H; Zhang Y; Shi J
    Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
    [No Abstract]   [Full Text] [Related]  

  • 49. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
    Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
    Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101.
    Li Z; Xu C; Ding B; Gao M; Wei X; Ji N
    J Neurooncol; 2017 Aug; 134(1):19-28. PubMed ID: 28551849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of long chain non-coding RNA CTBP1-AS in regulation of invasion and migration of breast cancer cells.
    Cui HB; Geng CZ
    J Biol Regul Homeost Agents; 2019 May-Jun,; 33(3):773-785. PubMed ID: 31165609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
    Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
    Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression.
    Xie JJ; Li WH; Li X; Ye W; Shao CF
    J Biol Regul Homeost Agents; 2019; 33(2):331-343. PubMed ID: 30972996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
    Gou L; Zou H; Li B
    Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
    Chang SM; Hu WW
    J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
    Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
    Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
    Luo S; Shen M; Chen H; Li W; Chen C
    Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195.
    Liu D; Zhu Y; Pang J; Weng X; Feng X; Guo Y
    J Cell Biochem; 2018 Feb; 119(2):1368-1380. PubMed ID: 28722813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.
    Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Liu Y
    Med Sci Monit; 2018 Dec; 24():8685-8692. PubMed ID: 30504754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.